用抗生素和全身疗法治疗腺炎的补充性管理
Stephen Kirchner1, Hakan Yesil2, Tarannum Jaleel2
1Department of Family Medicine, Mountain Area Health Education Center - MAHEC, 121 Hendersonville Road, Asheville, NC 28803, USA.
Dermatologic clinics
|March 1, 2025
概括
补腺炎 (HS) 的治疗重点是抗生素和传统疗法. 对于轻度至中度的HS而言,这些仍然至关重要,并且当生物药物无法获得时,对于严重病例的支持性护理至关重要.
科学领域:
- 皮肤病学 皮肤病学
- 炎症性疾病 炎症性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 补腺炎 (HS) 是一种慢性炎症性皮肤疾病.
- 目前的研究正在寻求新的治疗方法,但既有治疗方法仍然至关重要.
研究的目的:
- 审查已建立的HS局部和全身抗生素.
- 讨论包括激素调节剂,视网类药物和免疫抑制剂在内的常规系统疗法.
- 评估综合疗法在HS治疗中的作用.
主要方法:
- 对已知局部和全身抗生素的文献综述.
- 讨论广泛使用的全身性HS治疗方法.
- 对治疗组合及其临床相关性的分析.
主要成果:
- 抗生素和传统的全身疗法是HS不可或缺的第一线治疗方法.
- 激素调节疗法,视网类药物和免疫抑制剂是关键的系统选择.
- 组合疗法提供了进一步的管理策略.
结论:
- 对于轻度至中度的HS,传统治疗仍然很重要.
- 这些疗法可以作为辅助或桥梁治疗,当有针对性的生物药物由于成本,可用性或禁忌而无法获得时.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
88
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
88
Peptic Ulcer Disease IV: Management
58
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
58
Gastritis III: Clinical Manifestations and Management
115
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
115
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
315
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
315
Tonsillitis II: Management
100
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
100
Pleural Effusion II: Symptoms and Management
147
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
147


